Literature DB >> 27411311

Human cytomegalovirus miR-UL112-1 promotes the down-regulation of viral immediate early-gene expression during latency to prevent T-cell recognition of latently infected cells.

Betty Lau1, Emma Poole1, Ellen Van Damme2, Lieve Bunkens2, Madeleine Sowash1, Harry King1, Eain Murphy3, Mark Wills1, Marnix Van Loock2, John Sinclair1.   

Abstract

Human cytomegalovirus, a member of the herpesvirus family, can cause significant morbidity and mortality in immune compromised patients resulting from either primary lytic infection or reactivation from latency. Latent infection is associated with a restricted viral transcription programme compared to lytic infection which consists of defined protein coding RNAs but also includes a number of virally encoded microRNAs (miRNAs). One of these, miR-UL112-1, is known to target the major lytic IE72 transcript but, to date, a functional role for miR-UL112-1 during latent infection has not been shown. To address this, we have analysed latent infection in myeloid cells using a virus in which the target site for miR-UL112-1 in the 3' UTR of IE72 was removed such that any IE72 RNA present during latent infection would no longer be subject to regulation by miR-UL112-1 through the RNAi pathway. Our data show that removal of the miR-UL112-1 target site in IE72 results in increased levels of IE72 RNA in experimentally latent primary monocytes. Furthermore, this resulted in induction of immediate early (IE) gene expression that is detectable by IE-specific cytotoxic T-cells (CTLs); no such CTL recognition of monocytes latently infected with wild-type virus was observed. We also recapitulated these findings in the more tractable THP-1 cell line model of latency. These observations argue that an important role for miR-UL112-1 during latency is to ensure tight control of lytic viral immediate early (IE) gene expression thereby preventing recognition of latently infected cells by the host's potent pre-existing anti-viral CTL response.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27411311      PMCID: PMC5756489          DOI: 10.1099/jgv.0.000546

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  55 in total

Review 1.  Clinical aspects and management of cytomegalovirus infection.

Authors:  J G P Sissons; A J Carmichael
Journal:  J Infect       Date:  2002-02       Impact factor: 6.072

Review 2.  Cytomegalovirus.

Authors:  Paul D Griffiths; Simone Walter
Journal:  Curr Opin Infect Dis       Date:  2005-06       Impact factor: 4.915

3.  Cyclophilin A is required for efficient human cytomegalovirus DNA replication and reactivation.

Authors:  Lisa R Keyes; Mariana G Bego; Melisa Soland; Stephen St Jeor
Journal:  J Gen Virol       Date:  2012-01-13       Impact factor: 3.891

4.  Human microRNAs regulate stress-induced immune responses mediated by the receptor NKG2D.

Authors:  Noam Stern-Ginossar; Chamutal Gur; Moshe Biton; Elad Horwitz; Moran Elboim; Noa Stanietsky; Michal Mandelboim; Ofer Mandelboim
Journal:  Nat Immunol       Date:  2008-09       Impact factor: 25.606

5.  Human cytomegalovirus latent infection alters the expression of cellular and viral microRNA.

Authors:  Miao Fu; Yan Gao; Qiuju Zhou; Qi Zhang; Ying Peng; Kegang Tian; Jinhua Wang; Xiaoqun Zheng
Journal:  Gene       Date:  2013-12-18       Impact factor: 3.688

Review 6.  Transfusion-associated cytomegalovirus infections.

Authors:  S P Adler
Journal:  Rev Infect Dis       Date:  1983 Nov-Dec

7.  Latent infection of myeloid progenitors by human cytomegalovirus protects cells from FAS-mediated apoptosis through the cellular IL-10/PEA-15 pathway.

Authors:  Emma Poole; Jonathan C H Lau; John Sinclair
Journal:  J Gen Virol       Date:  2015-05-08       Impact factor: 3.891

8.  HCMV protein LUNA is required for viral reactivation from latently infected primary CD14⁺ cells.

Authors:  Lisa R Keyes; Danna Hargett; Melisa Soland; Mariana G Bego; Cyprian C Rossetto; Graca Almeida-Porada; Stephen St Jeor
Journal:  PLoS One       Date:  2012-12-26       Impact factor: 3.240

9.  Detection of endogenous human cytomegalovirus in CD34+ bone marrow progenitors.

Authors:  M Mendelson; S Monard; P Sissons; J Sinclair
Journal:  J Gen Virol       Date:  1996-12       Impact factor: 3.891

10.  Cellular defense against latent colonization foiled by human cytomegalovirus UL138 protein.

Authors:  Song Hee Lee; Emily R Albright; Jeong-Hee Lee; Derek Jacobs; Robert F Kalejta
Journal:  Sci Adv       Date:  2015-11-27       Impact factor: 14.136

View more
  28 in total

1.  The Golgi sorting motifs of human cytomegalovirus UL138 are not required for latency maintenance.

Authors:  Christopher B Gelbmann; Robert F Kalejta
Journal:  Virus Res       Date:  2019-06-28       Impact factor: 3.303

Review 2.  Immunomodulatory roles of human herpesvirus-encoded microRNA in host-virus interaction.

Authors:  Afsar R Naqvi
Journal:  Rev Med Virol       Date:  2019-08-20       Impact factor: 6.989

Review 3.  MicroRNA Regulation of Human Herpesvirus Latency.

Authors:  Siyu Chen; Yue Deng; Dongli Pan
Journal:  Viruses       Date:  2022-06-02       Impact factor: 5.818

Review 4.  Human Cytomegalovirus Host Interactions: EGFR and Host Cell Signaling Is a Point of Convergence Between Viral Infection and Functional Changes in Infected Cells.

Authors:  Byeong-Jae Lee; Chan-Ki Min; Meaghan Hancock; Daniel N Streblow; Patrizia Caposio; Felicia D Goodrum; Andrew D Yurochko
Journal:  Front Microbiol       Date:  2021-05-07       Impact factor: 5.640

5.  Human cytomegalovirus microRNAs are carried by virions and dense bodies and are delivered to target cells.

Authors:  Abdul-Aleem Mohammad; Helena Costa; Natalia Landázuri; Weng-Onn Lui; Kjell Hultenby; Afsar Rahbar; Koon-Chu Yaiw; Cecilia Söderberg-Nauclér
Journal:  J Gen Virol       Date:  2017-05       Impact factor: 3.891

6.  The Mechanism of Synchronous Precise Regulation of Two Shrimp White Spot Syndrome Virus Targets by a Viral MicroRNA.

Authors:  Yaodong He; Tiantian Ma; Xiaobo Zhang
Journal:  Front Immunol       Date:  2017-11-27       Impact factor: 7.561

7.  A BMPR2/YY1 Signaling Axis Is Required for Human Cytomegalovirus Latency in Undifferentiated Myeloid Cells.

Authors:  Emma Poole; Maria Cristina Carlan da Silva; Chris Huang; Marianne Perera; Sarah Jackson; Ian J Groves; Mark Wills; Amer Rana; John Sinclair
Journal:  mBio       Date:  2021-06-01       Impact factor: 7.867

8.  Regulation of host and viral promoters during human cytomegalovirus latency via US28 and CTCF.

Authors:  Elizabeth G Elder; Benjamin A Krishna; Emma Poole; Marianne Perera; John Sinclair
Journal:  J Gen Virol       Date:  2021-05       Impact factor: 5.141

9.  Latency-Associated Expression of Human Cytomegalovirus US28 Attenuates Cell Signaling Pathways To Maintain Latent Infection.

Authors:  Benjamin A Krishna; Emma L Poole; Sarah E Jackson; Martine J Smit; Mark R Wills; John H Sinclair
Journal:  mBio       Date:  2017-12-05       Impact factor: 7.867

10.  Targeting the latent human cytomegalovirus reservoir for T-cell-mediated killing with virus-specific nanobodies.

Authors:  Timo W M De Groof; Elizabeth G Elder; Eleanor Y Lim; Raimond Heukers; Nick D Bergkamp; Ian J Groves; Mark Wills; John H Sinclair; Martine J Smit
Journal:  Nat Commun       Date:  2021-07-21       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.